Financials

  • Market Capitalization 41.09 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
214
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
756.01 USD-0.89%+2.20%-4.18%+35.75%77.84 B USD
313
ARGX
argenx SE - American Depositary Shares
805.17 USD-0.88%-14.33%-19.85%+0.80%49.83 B USD
448
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
223.90 USD-1.37%-2.21%-10.50%-51.55%29.96 B USD
492
RPRX
Royalty Pharma plc - Class A Ordinary Shares
56.84 USD-1.63%+0.25%-3.10%+52.55%25.38 B USD

Notizie